Unadjusted and adjusted clinical and safety outcomes in patients with M2 segment MCA occlusions
| Outcome | Endovascular treatment group, % (n/N) | Control group, % (n/N) | Unadjusted | Adjusted | ||
| Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |||
| mRS 0–2 | 58.2% (39/67) | 39.7% (25/63) | 2.13 (1.05 to 4.35) | 0.04 | 2.39 (1.08 to 5.28) | 0.03 |
| mRS at 90 days | N/A | N/A | 1.88 (1.01 to 3.49) | 0.05 | 1.77 (0.94 to 3.36) | 0.08 |
| mRS 0–1 | 37.3% (25/67) | 20.6% (13/63) | 2.62 (0.92 to 7.45) | 0.07 | 2.71 (0.83 to 8.83) | 0.10 |
| NIHSS 0–2 at 24 hours | 26.9% (18/67) | 8.2% (5/61) | 4.11 (1.42 to 11.9) | 0.01 | 3.82 (1.22 to 11.95) | 0.02 |
| sICH | 0.0% (0/67) | 7.9% (5/63) | 0 | 0.03 | – | – |
| Death | 11.9% (8/67) | 9.5% (6/63) | 1.29 (0.42 to 3.95) | 0.66 | 1.33 (0.38 to 4.7) | 0.66 |
mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Score; sICH, symptomatic intracerebral hemorrhage.